Yun B. Wang
Pr
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 191 publications
BCMA versus GPRC5D bispecific antibodies in relapsed/refractory multiple myeloma: A systematic review and meta-analysis guiding treatment selection.
Journal: British journal of haematology
Published: March 22, 2026
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Journal: The New England journal of medicine
Published: December 03, 2025
Plasma proteomic profiling uncovers the age-related molecular changes in chronic obstructive pulmonary disease.
Journal: BMC pulmonary medicine
Published: October 29, 2025
Machine learning-based association analysis of triglyceride-glucose index with melanoma prevalence and all-cause mortality: insights from cross-sectional NHANES 1999-2018 data and an external hospital-based dataset.
Journal: Frontiers in nutrition
Published: October 17, 2025
Real-World Efficacy of Nab-Paclitaxel Plus Capecitabine and a PD-1 Inhibitor in Metastatic or Locally Advanced Esophageal Cancer.
Journal: Cancer medicine
Published: October 13, 2025
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.
Journal: Leukemia
Published: October 07, 2025
Engineered M2 macrophage-derived extracellular vesicles reprogram mitochondrial metabolism to alleviate temporomandibular joint cartilage degeneration.
Journal: Materials today. Bio
Published: September 29, 2025
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study.
Journal: Annals of hematology
Published: September 09, 2025
CRISPR-SDA: an integrated isothermal amplification and CRISPR-Cas12a biosensing platform for sensitive detection of microRNA-21.
Journal: Analytical methods : advancing methods and applications
Published: September 01, 2025
Corrigendum to "Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance" [Cancer Lett. (2018) 412 243-255].
Journal: Cancer letters
Published: August 20, 2025
Last Updated: 09/26/2026